Building the future of healthcare on patient engagement
FRAMINGHAM, Mass., January 19, 2023 /PRNewswire/ — Alira Saluteglobal healthcare consulting, clinical research and technology company, is pleased to announce today the appointment of Annabel of Mary as Chief Patient Officer. In this leadership capacity, she will lead the central role of patient engagement across Alira Health’s healthcare innovation services continuum. Annabel brings an extensive background and noteworthy experience with over twenty years in the healthcare industry, both as an in-house executive and as a freelance consultant, focusing on the patient engagement industry. She initially joined Alira Health as Vice President of Patient Engagement in October 2020and is based on that of the company Barcelona, Spain office.
“At Alira Health, we truly believe that patients should be at the heart of everything we do,” she said Gabriel Brambilla, CEO and co-founder of Alira Health. “I am proud to have Annabel lead this critically important position as our Chief Patient Officer, in partnership with all of our Alira Health teams and services. Her guidance and leadership enable us to partner with patients throughout the entire cycle. of a drug or medical device We work with clinical teams to jointly develop clinical trial protocols with patients We research diseases with patients around the world to understand the patient journey and apply knowledge to protocols trials, regulatory submissions, Health Technology Assessments (HTA), and commercialization. We help companies define patient-centric strategies and create patient support programs. Alira Health focuses on co-creating healthcare solutions with patients for our customers.Annabel will play a vital role in building the future of healthcare on patient engagement.”
“I am honored to bring the voice of the patient, in collaboration with Alira Health teams, our customers and our global partnerships, in this central role of Chief Patient Officer,” Annabel of Mary She said. “For more than twenty-five years, I have focused my Pharmaceutical and MedTech professional experience on patient engagement, working to understand the patient journey through many important diseases and to implement innovative plans to support and advocate for patients.”
In her previous role as Vice President of Patient Engagement, Annabel led Alira Health’s Patient Engagement practice, where she helped clients bring patient-centric activities into their organizations in a meaningful way. The practice is dedicated to helping organizations harness the power of patient insights, using them to make better decisions, influence outcomes, and improve the patient experience. The practice’s services include the development of patient-centered strategies, a patient knowledge center, advisory boards, and mobilization programs to facilitate true and fruitful interactions that serve stakeholders across the ecosystem and benefit patients.
Annabel assumes her role as Chief Patient Officer effective immediately. Prior to joining Alira Health, Annabel was Head of Corporate Communications at Almirall and Head of Media Relations Europe at Nestlé Purina. As a consultant, her work has focused on global strategy for Champix, Lucentis and Pradaxa. Annabel’s early career included the Spanish launches of Celebrex, Detrusitol and Xalatan, with subsequent positions at Pfizer, Bayer and Novartis Spain. In addition to her role at Alira Health, Annabel teaches patient engagement at Bocconi University and is a patient advocate for the EULAR working group on autoinflammatory diseases.
About Alira Health
Alira Health is a global clinical research and consulting company whose mission is to humanize healthcare and life sciences, in partnership with patients, through innovative technologies and expert guidance. From development to medical care, Alira Health integrates the expertise of its Pharmaceutical, Biotech and MedTech clients with a full range of services throughout the entire lifecycle of their solutions. Learn more: www.alirahealth.com
SOURCE Alira Salute